The latest probe points to challenges for India’s biggest drugmaker after whistle-blower complaints on corporate governance lapses triggered a stock slide last year.
In 2015, billionaire Dilip Shanghvi bought 23% stake for Rs 18 billion, but Suzlon still hasn’t exited India’s debt-restructuring program, missing deadlines since 2017.
Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.
India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.
Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.
Big Pharma, such as, Johnson and Johnson, Abbott, Purdue that were responsible for causing opioid crisis in USA are shifting their shops to India to peddle their poison here. They are facing immense pressure in US with a slew of court filings and billions in restitution.
Source: https://www.theguardian.com/world/2019/aug/27/india-opioids-crisis-us-pain-narcotics
Big Pharma, such as, Johnson and Johnson, Abbott, Purdue that were responsible for causing opioid crisis in USA are shifting their shops to India to peddle their poison here. They are facing immense pressure in US with a slew of court filings and billions in restitution.
Source: https://www.theguardian.com/world/2019/aug/27/india-opioids-crisis-us-pain-narcotics